Dr. Aaron Kelly's research on GLP-1 weight loss drugs for children with obesity has sparked significant interest and controversy, highlighting both their potential benefits and the urgent need to address the broader environmental factors contributing to childhood obesity, rather than solely relying on medication as a solution. #ChildObesity #Nutrition #PublicHealth #US #CA #LA
www.nytimes.com
Opinion | If Kids Need GLP-1s, We've Already Let Them Down
Ms. Belluz is a contributing Opinion writer covering health, nutrition and chronic illness.
When Dr. Aaron Kelly began studying the effects of GLP-1 weight loss drugs in children with obesity, he thought it would be difficult to recruit patients.